Texas Fertility Center (TFC) is a world leader in infertility research

Since our founding in 1980, our team has been performing groundbreaking research that improves fertility care and outcomes for patients like you.  Our past research studies have included IVF, preimplantation genetic testing (PGT), endometriosis, polycystic ovary syndrome (PCOS), pelvic adhesions and uterine fibroids.

New Research at Texas Fertility

LOTUS Study (Enrolling Start Date 08/01/2022)
Evaluation of the Alife Hera System as an Adjunctive Tool for the Prioritization of Embryos Deemed Suitable for Transfer: A Randomized Controlled Study.

What is the purpose of this study? To evaluate whether the adjunctive use of the Hera System (Hera System used with traditional morphological grading) with embryos already deemed suitable
for transfer is non-inferior to trained embryologists using standard morphology criteria alone in clinical pregnancy rate, defined as fetal heartbeat at 6-8 weeks.

What is the purpose of this study?
To evaluate whether the adjunctive use of the Hera System (Hera System used with traditional morphological grading) with embryos already deemed suitable for transfer is non-inferior to trained embryologists using standard morphology criteria alone in clinical pregnancy rate, defined as fetal heartbeat at 6-8 weeks.

Number of patients to be enrolled:  450 patients

What are the qualifications?  Participants undergoing in vitro fertilization treatment with a planned transfer, who fulfill all eligibility criteria. Eligibility criteria can be assessed by personnel involved in the study. Please contact Margaret Wozniak  at 512-910-3402 ext. 9058 to see if you qualify.

Learn more about the study here.